H. Lundbeck AS (CHIX:HLUNBC) Accounts Payable & Accrued Expense : kr6,788 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Accounts Payable & Accrued Expense?

H. Lundbeck AS's quarterly accounts payable & accrued expense declined from Jun. 2024 (kr6,855 Mil) to Sep. 2024 (kr6,632 Mil) but then increased from Sep. 2024 (kr6,632 Mil) to Dec. 2024 (kr6,788 Mil).

H. Lundbeck AS's annual accounts payable & accrued expense increased from Dec. 2022 (kr6,774 Mil) to Dec. 2023 (kr6,918 Mil) but then declined from Dec. 2023 (kr6,918 Mil) to Dec. 2024 (kr6,788 Mil).

H. Lundbeck AS Accounts Payable & Accrued Expense Historical Data

The historical data trend for H. Lundbeck AS's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Accounts Payable & Accrued Expense Chart

H. Lundbeck AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

6,261.00

7,083.00

6,774.00

6,918.00

6,788.00

H. Lundbeck AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															6,918.00	6,701.00	6,855.00	6,632.00	6,788.00

H. Lundbeck AS Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

H. Lundbeck AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (CHIX:HLUNBc) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

HLBBF:USA HLUBF:USA 0ABR:UK 0ND5:UK HLUN A:Denmark HLUN B:Denmark LDBB:Germany LUNB:Austria LUNA:Austria

Address

Ottiliavej 9, Valby, DNK, 2500

Website

https://www.lundbeck.com

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS Headlines

No Headlines